Zenith Drugs (NSE:ZENITHDRUG) Accounts Payable: ₹556 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ZENITHDRUG Zenith Drugs Ltd NSE:ZENITHDRUG
35 GF Score
Price ₹47.80
! 8 Warning Signs
View Full Analysis

What is Zenith Drugs Accounts Payable?

Zenith Drugs NSE:ZENITHDRUG +4.03% 35 Accounts Payable is ₹556 Mil as of Mar. 2026. GuruFocus rates NSE:ZENITHDRUG with a GF Score™ of 35/100. The stock has 8 warning signs investors should review.

Zenith Drugs's Accounts Payable for the quarter that ended in Mar. 2026 was ₹556 Mil.

Zenith Drugs's quarterly Accounts Payable declined from Mar. 2025 (₹402 Mil) to Sep. 2025 (₹366 Mil) but then increased from Sep. 2025 (₹366 Mil) to Mar. 2026 (₹556 Mil).

Zenith Drugs's annual Accounts Payable declined from Mar. 2024 (₹426 Mil) to Mar. 2025 (₹402 Mil) but then increased from Mar. 2025 (₹402 Mil) to Mar. 2026 (₹556 Mil).

Zenith Drugs Accounts Payable Historical Data

* Premium members only.

The historical data trend for Zenith Drugs's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zenith Drugs Accounts Payable Chart

Zenith Drugs Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Accounts Payable
Get a 7-Day Free Trial 346.81 508.74 426.31 401.84 555.89

Zenith Drugs Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only 426.31 0.00 401.84 365.56 555.89
NSE:ZENITHDRUG
35GF Score
Zenith Drugs Ltd NSE:ZENITHDRUG
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zenith Drugs Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of ₹556 Mil mean?
Zenith Drugs (NSE:ZENITHDRUG) has a Accounts Payable of ₹556 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Zenith Drugs and its competitors.
Is Zenith Drugs' Accounts Payable too high?
Zenith Drugs' current Accounts Payable is ₹556 Mil. Overall, Zenith Drugs has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Zenith Drugs' Accounts Payable compare to ZTS?
Zenith Drugs' Accounts Payable of ₹556 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Zenith Drugs and its competitors. Zenith Drugs's current Accounts Payable is ₹556 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zenith Drugs stock overvalued right now?
Zenith Drugs (NSE:ZENITHDRUG) has a current Accounts Payable of ₹556 Mil. The current Accounts Payable is ₹556 Mil. Zenith Drugs' overall GF Score™ is 35/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Zenith Drugs (NSE:ZENITHDRUG), the current Accounts Payable is ₹556 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Zenith Drugs Business Description

Address K. No. 72/5, Village Muradpura, Depalpur, Indore, MP, IND, 453001
Zenith Drugs Ltd is a pharmaceutical manufacturing and trading company. It offers a wide range of formulations in various forms such as ORS Powder, Liquid Orals, Ointments, Liquid Externals, Creams, Gels, Capsules, and Tablets. It is also into Generic Medicines.
35GF Score

Get the complete analysis for NSE:ZENITHDRUG

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹47.80
Price